Abstract. Glia-promoting factors (GPFs) are peptides of the central nervous system which accelerate the growth of specific glial populations in vitro. Although these factors were first discovered in the goldfish visual system
of the central nervous system which accelerate the growth of specific glial populations in vitro. Although these factors were first discovered in the goldfish visual system (Giulian, D., Y. Tomozawa, H. Hindman, and R. Allen, 1985, Proc. Natl. Acad. Sci. USA., 83:4287-4290), we now report similar peptides are found in mammalian brain. The cerebral cortex of rat contains oligodendroglia-stimulating peptides, GPF, (15 kD) and GPF3 (6 kD), as well as astroglia-stimulating peptides, GPF2 (9 kD) and GPF4 (3 kD).
The concentrations of specific GPFs increase in brain during periods of gliogenesis. For example, GPF, and GPF3 are found in postnatal rat brain during a peak of oligondendroglial growth while GPF2 and GPF4 are first detected at a time of astroglial proliferation in the embryo. Stab wound injury to the cerebral cortices of rats stimulates astroglial proliferation and induces marked elevations in levels of GPF2 and GPF4. Our findings suggest that two distinct classes of GPFs, those acting upon oligodendroglia and those acting upon astroglia, help to regulate cell growth in the developing and injured central nervous system.
LIAL cells and their precursors play an important role in organizing patterns of neuronal growth during development of or following injury to the central nervous system (1, 19, (25) (26) (27) (28) . Singer et al., for example, propose that primitive glia form channels which align and direct growing axons in the developing spinal cord of newt (28) . In fetal mammalian brain, glia aid neuronal migration (25) and help to regulate growth of axons across the corpus callosum (27) . During such glia-neuron interactions, it is likely that stimulatory signals are needed to activate glia which in turn create an environment suitable for growing axons. The biochemical basis for glial "activation" remains unknown.
Study of the regenerating goldfish visual system showed that peptides recovered from the optic tectum stimulated proliferation of fish macroglia (6, 8, 9) . These fish peptides, referred to as glia-promoting factors (GPFs), ~ were also mitogens for mammalian cells in culture (12) with GPF~ and GPF3 acting upon oligodendroglia and GPF2 and GPF4 stimulating astroglia. Our observations suggested that GPF-like factors might also be found in neural tissues of mammals. We now report the presence of GPFs in the developing and injured rat brain. It appears that two distinct classes of GPFs, the astroglia-stimulating peptides and the oligodendroglia-stimu~Abbreviations used in this paper: Dulbecco's MEM, Dulbecco's minimal essential medium; EGF, epidermal growth factor; FCS, fetal calf serum; FGF, fibroblast growth factor; GC, galactocerebroside; GFAP, glial fibrillary acid protein; GMF, glial maturation factor; GPF, glia-promoting factor; GS, goat serum: lL-l and -2, Interleukin-l and -2.
lating peptides, stimulate gliogenesis in the central nervous system of mammals.
Materials and Methods

Preparation of Cell Cultures
Mixed glial cultures were prepared from the brains of newborn rats and gown on coverslips coated with poly-L-lysine. Cerebral cortices from rat were stripped of meninges and isolated in ice-cold calcium-and magnesium-free phosphatebuffered saline (PBS) (pH 7.4) (10). Tissue was then placed in chemically defined medium (4) containing DNase (l mg/ml; Sigma Chemical Co., St. Louis, MO), and minced with iridectomy scissors. After addition of trypsin (0.2% wt/vol; Sigma Chemical Co.), tissue fragments were dissociated by trituration. Cells in suspension were collected and washed twice with defined medium containing 10% fetal calf serum (FCS) (Gibco, Santa Clara, CA) which stopped the enzymatic dissociation. Cell viability was determined by erythrosin B exclusion using a hemocytometer; between 800,000 and 1,000,000 viable cells in defined medium with 10% FCS were added to 35-ram plastic culture dishes that contained 22-mm square coverslips (Fisher Scientific Co., Pittsburgh, PA) coated with poly-L-lysine (Sigma Chemical Co.). After 48 h, cells were washed three times with defined culture medium and used for bioassays as described below. Enriched populations of astroglia and oligodendroglia were obtained using the method of McCarthy and de Vellis (18) . The glial cell line C6 (American Type Culture Collection, Rockville, MD; CCL # 107) was gown in 100-mm plastic dishes containing defined medium. dipped sequentially in 100% acetone, 70% ethanol, PBS, and Dulbecco's MEM-I% FCS. Rabbit anti-human GFAP-serum (whole serum; Accurate Chemical & Scientific Corp., Westbury, NY) was diluted with Dulbeceo's MEM containing 1% goat serum (Dulbecco's MEM-I% GS) to a concentration of 1:200, and applied directly to the coverslips. Coverslips were incubated for 45 min at 37"C in 95% air/5% CO2 with high humidity and then washed with Dulbecco's MEM-1% FCS. A goat anti-rabbit immunoglobulin conjugate of rhodamine isothiocynate (Accurate Chemical & Scientific Corp.) diluted to 1:100 with Dulbecco's MEM-I% GS was next applied for 45 min at 37"C. Coverslips were washed five times with Dulbecco's MEM-I% FCS and mounted in solution containing 1 mg/ml p-phenylenediamine, 10% PBS, and 90% glycerol at pH 8.0, Fluorescence-labeled cells were viewed at 200x magnification with a Nikon inverted microscope using epifluorescence. Oligodendroglia containing galactocerebroside (GC) were identified by indirect immunofluoreseence using anti-GC serum. The technique was similar to that of astroglia except that cells were fixed after antibody binding. Rabbit anti-GC serum produced by our laboratory and by Dr. T. Inagami of Vanderbilt University (Nashville, TN) was diluted to 1:100 using Dulbecco's MEM-1% GS. In addition, monoclonal antibody against GC (ascites fluid was a gift from Dr. Barbara Ranscht) was diluted 1:200 and applied in a similar fashion with a goat anti-mouse immunoglobulin conjugate of Texas Red (1:50; Accurate Chemical & Scientific Corp.) serving as the fluorescent label.
Neuroglial progenitor cells containing the A2B5 surface antigen were also identified by immunofluorescence techniques (22). Mouse ascites fluid (A2B5 hybridoma from American Type Culture Collection #CRL 1520) diluted 1:50 was applied as described for GC with Texas Red (1:50) serving as the fluorescent conjugate. Rabbit anti-Thy-I serum (1:100; Accurate Chemical & Scientific Corp.) was used to label fibroblasts (24) by the method described for GFAP. Micruglia were identified as phagocytic cells, containing nonspecific esterase, acetylated low density lipoprotein receptors, and the Mac-I and Mac-3 antigens (7. 24).
The cellular composition of untreated 3-d cultures of newborn rat cerebral cortex is shown in Table I . Approximately 35-45% of cells were fibroblastic astroglia containing glial flbrillary acidic protein (GFAP+). These cells were A2B5 <-) and corresponded to the Type 1 astrocyte described by Raffet al. (22). The Thy-I ~+) fibroblasts made up <1% of all cells in culture and were not evaluated further in this study. Microglia represented ~5-7% of all cells in culture, while GC t+> oligodendroglia contributed between 3-6% of the cell populations. Approximately 20% of cells in rat brain cultures were A2B5(+~; nearly all of these cells were GC ~-), GFAP ~-~, round in shape, and some contained thin, short processes. We assumed that most of the A2B5 t÷~ cells and the remaining unstained fibroblastic cells were progenitor cells of macroglia (22-24).
Selective Cell Destruction
Oligodendroglia were selectively destroyed by a complement lysis technique (22). Cells grown on poly-L-lysine-coated coverslips were washed three times with defined medium, covered with 100 ~1 of medium containing anti-GC serum (1:100 dilution), and placed in a humidified incubator with a 95% air/ 5% CO2 atmosphere for 30 min at 37"C. After two washes with defined media, 100 ~1 of medium containing guinea pig complement (hi0 dilution, Sigma Chemical Co.) were added for an additional 60 rain at 37*(?. With these conditions, <0.1% of remaining cells were intact GC t+> oligodendroglia.
A similar method was used to lyse A2B5 ~÷~ cells with an incubation of A2B5 hybridoma ascites fluid (1:100) for 30 min followed by complement lysis (1:50) for 30 min. Under these conditions, >99% of all A2B5 ~÷) cells were eliminated.
To destroy microglia, cell suspensions were incubated with 5 mM L-leucine methyl ester in defined medium for 3 h at 37"C (7, 30) . Glia populations found in cultures of cerebral cortex from brains of newborn rat. After 3 d in vitro, cells were identified using the specific markers described in Materials and Methods.
GPF Isolation and Bioassay
Transection of the goldfish optic tract was carried out 1.0-1.5 mm before its entry into the rectum. An intact contralateral visual system provided control tissue (6) . Optic tecta were isolated 10 d after axotomy and frozen at -20"C. Tissues were dispersed by mild sonication in PBS (pH 7.4) and centrifuged at 15,000 g for 30 min (Microfuge). Supernatants were pooled, passed through a 0.45-um filter (Millipore/Continental Water Systems, Bedford, MA), and separated by a gel filtration column (100 x 0.9 cm, PI0; Bio-Rad Laboratories, Richmond, CA). Embryos and neonates from albino rats (Holtzman Co., Madison, Wi) were the source of GPFs during development. Stab wound injury to the cerebral cortices of anesthetized adult rats was carried out as described earlier (10) . GPFs were recovered from rat brain in a fashion identical to that of the fish factors. Partially purified GPFs were identified by monitoring glia-stimulating activity in fractions recovered from gel filtration. Pooled fractions were added to culture dishes that contained 1.5 ml of chemically defined medium to give final GPF concentrations ranging from 0.1 to 10 ug protein/ml medium. Protein determinations were estimated by the fluorescamine method using bovine serum albumin standards (3).
Peptide Hormones
Partially purified fibroblasts growth factor (FGF) and epidermal growth factor (EGF) were obtained from Collaborative Research (Lexington, MA). Partially purified glial maturation factor (GMF) was a gift from Dr. R. Lim 
Glutamine Synthetase Assay
200,000 cells of the C6 glial line were grown on 100-ram plastic culture dishes in defined medium with 10% FCS. Dishes were washed three times with defined medium and incubated with 3.0 ml of defined medium containing 200/~1 of partially purified GPFs or PBS. After 48 h, cultures were washed twice with PBS and lysed with 500 ul of 50 mM N-morpholino ethane sulfonic acid buffer (pH 7.0) containing 1% Nonidet P-40 (Sigma Chemical Co.). Cells were removed with a rubber policeman and dispersed by sonication into 1.5-ml conical tubes. Enzyme assays were carried out in triplicate with protein concentrations ranging from 0.27 to 0.39 mg/ml. To measure glutamine synthetase activity, 100 ul of the lysate was incubated with 900 ~1 of the substrate solution (50 mM imidazole-HCL buffer, [pH 7.2]; 20 mM MgCIz.6 H20; 50 mM Lglutamic acid; 0.11 M hydroxylamine; 30 mM 2-mereaptoethanol; 10 mM phosphoenolpyruvate; 20 mM ATP; and 50 U of pyruvate kinase (Sigma Chemical Co.) (15) . After 60 min at 37"C, the reaction was stopped by the addition of 1.5 ml of solution containing 370 mM FeC13 and 200 mM trichloroacetic acid, and the mixture was centrifuged at 15,000 g (Microfuge) for 15 rain at 4"C. The reaction product was measured at 535 nm (Model 250, Gilford Instrument Laboratories, Inc., Oberlin, OH) against blanks containing 50 mM N-morpholino ethane sulfonic acid buffer only. Specific activity for glutamine synthetase was expressed as #mol of "v-glutamylhydroxamic acid formed per microgram of protein per hour.
Results
GPFs in Mammalian Brain
As reported earlier (12) , peptides isolated from the goldfish visual system stimulated growth of specific populations of rat brain glia. The response of mammalian cells to fish GPFs suggested that growth factors with similar biological activities existed within mammalian brain. Accordingly, we screened for the presence of GPFs in the central nervous system of rat. Supernatants from newborn rat cerebral cortex contained gliastimulating factors. Gel filtration separated two peaks of growth activity specific for oligodendroglia. These factors with molecular masses of 15 and 6 kD ( Fig. 1) corresponded to GPF~ and GPF3 found in the goldfish optic tectum ( Fig. 2 ; reference 12). Astroglia-stimulating factors recovered from newborn rat brain (Fig. 1 ) included 9-and 3-kD peaks corresponding to fish GPF2 and GPF4 (Fig. 2) . The glia-stimulating were applied to a gel filtration column (P-10, 100 x 0.9 cm) and eluted with sterile PBS (pH 7.4). 100-#1 aliquots taken from the 700-pl fractions were incubated for 72 h with glial cultures grown in defined medium on poly-L-lysine--coated glass coverslips. Using immunofluorescence techniques, astroglia were identified as GFAt x÷) cells and oligodendroglia as GO *) ones. Mean cell counts were determined by scoring the number of glia found in 10 randomly selected fields. Data are expressed as fold increase in a specific glial population when compared with control cultures treated with equivalent volumes of PBS. Three coverslips were used for each data point (A.). Two peaks of oligodendroglia-promoting activity were recovered with apparent molecular masses of 15 kD (GPFt) and 6 kD (GPF3) (B.). Three peaks of astroglia-promoting activity were recovered with apparent molecular masses of 18 kD, 9 kD (GPF2) and 3 kD (GPF4). factors recovered from rat brain were trypsin-sensitive peptides ( Fig. 3 ) and co-purified with fish GPFs isolated by anion exchange chromatography and by reverse-phase high performance liquid chromatography ( 1 l). Based upon similarities in biological activities, apparent molecular masses, and elution profiles, we concluded that GPFs from rat brain were structurally similar to GPFs isolated from goldfish optic tectum. In addition, the rat brain contained an 18-kD peptide ( Fig. 1 ) that stimulated astrogha in culture; this factor was not detected in fish optic tecta and subsequently has been identified as IL-l (10).
GPFs and Target Cell Specificity
GPFs might stimulate the appearance of differentiated glia (i.e., GC (+) or GFAI ~+) cells) in culture by acting directly upon specific target cells or indirectly by eliciting growth factors from neighboring cells. To monitor the direct effects of GPFs, we used enriched cultures of astroglia or oligodendroglia. In these enriched cell preparations, we obtained populations of either 90% GO +) oligodendroglia (with < 1% astroglia) or 98% (Figs. 4 and 5) . These findings support the idea that GPFs influenced cell growth by direct action upon specific target cell populations.
A variety of peptides isolated from mammalian tissues have been found to stimulate proliferation of astroglia or Schwann cells in culture (10, 13, (15) (16) (17) . Since the relationship of such peptides to GPFs was unknown, we compared the biological actions of GPFs with GMF, EGF, and FGF. As shown in Fig.  6 , partially purified GPF~ stimulated the appearance ofG-O +) oligodendroglia in a dose-dependent fashion, although it had little effect upon astrogiial number. Other various peptides, including GPF2, GMF, EGF, and FGF (Fig. 6) , did not change the number of oligodendroglia found in culture. In addition neurotensin, IL-1, IL-2, and #-endorphin (data not shown) had no effect on the growth of oligodendroglia. The specificity of action for oligodendroglia-stimulating peptides suggested that GPF~ and GPF3 represented a unique class ofglia-specific growth factor.
We found that a number of peptides, including EGF, FGF, and GPF2 (Fig. 6) , served as mitogens for GFAI ~+) astroglia. Although the astroglia-stimulating GPFs might be similar to other growth factors, GPF2 did not co-purify with EGF, FGF, or IL-l by gel filtration chromatography (data not shown). Moreover, GPF2 was inactive in the thymocyte stimulation assay for IL-1 (10) and did not compete for EGF-binding sites (data not shown). Further attempts to compare GPF2 with other peptides will require biochemical analyses of purified factors. We also examined the target selectivity of GPFs by measuring their ability to induce glutamine synthetase, an enzyme associated with brain astrocytes. Other investigators have established that the levels of glutamine synthetase correlate with the degree of astroglial differentiation (5, 14, 20) . Our initial study showed that the basal activity of this enzyme increased by 1.5-2.0-fold in newborn rat brain cultures after incubations for 48 h with the astroglia-stimulating peptide GPF2 (1 #g protein/ml culture medium). We followed this enzyme induction more closely by comparing the abilities of different GPFs to stimulate giutamine synthetase in the glial cell line C6, a population of poorly differentiated cells with astrogliai properties (2) . Incubations with GPF2 increased the levels of enzyme activity by fivefold above those found in untreated C6 cultures and by threefold above those measured in cultures incubated with the oligodendroglia-stimulating peptide GPFj (Table II) . The findings suggested that specific GPFs might induce astroglial differentiation in the developing brain.
Effects of GPFs Upon Survival, Differentiation, and Proliferation of Gila
Incubation of newborn rat brain cells with GPFs markedly increased the percent of differentiated astroglia or oligodendroglia when compared to control cultures (Table III) . The greater number of glia found after GPF incubation might reflect an increase in the survival time of cells grown in chemically defined culture medium. Cell counts showed, however, that after 7 d, untreated cultures increased their total cell number by 150-250%, with no significant cell death under the culture conditions used. Thus, increased cell survival times alone did not account for the abilities of GPFs to increase glial cell number.
Alternatively, GPFs might act either by accelerating the expression of glial markers among undifferentiated cells or by stimulating proliferation of mature cells. To test the ability of GPF, to stimulate undifferentiated cells, we first destroyed differentiated oligodendroglia that contained the surface antigen GC by complement lysis. The remaining cells were then treated with GPFI. By 3 d after GPFI incubation, more than 50% of the total cell population contained GC ~+) oligodendroglia compared with 1.0% GC ~+1 cells found in the control cultures lacking GPFI (Fig. 7) . These findings indicated that undifferentiated glia were sensitive to the effects of GPF,.
The surface antigen A2B5 has been identified in a variety of neuro-epithelial cells during embryogenesis (22). Raft et al. (12) have found that A2B5 ~+) stem cells differentiate into GC ~+) oligodendroglia and can be distinguished from A2B5 ~-) stem cells which develop into fibroblastic GFAP ~+~ astrogiia. We monitored the A2B5 ~+) cell population in cultures of newborn rat brain treated with GPFs. There was a two-fold increase in the number of A2B5 <+1 progenitor cells after incubation with GPF~ although not after incubation with GPF2 (Table IV) . These data supported the notion that GPF, acted upon a target cell population distinct from that of GPF2.
The response of A2B5 ~÷) cells to GPF, raised the possibility that oligodendroglia in the early stages of differentiation (i.e., G~ -) A2B5 ~+) and CJ~ +> A2B5 ~+1) cells were targets for peptide factors. We could not rule out this possibility using routine cultures, for oligodendroglia (isolated by the method of McCarthy) contained fully differentiated C_J(3 +> A2B5 <-1 cells as well as the less mature A2B5 t+) ones. Destruction of all A2B5 <+1 cells by complement lysis allowed us to test the effects of GPFt upon fully differentiated cultures. Under these conditions we found that GPFI caused a proliferation of GC ~÷> A2B5 I-) oligodendroglia (Fig. 8) . GPFt also stimulated these cells to incorporate [3H]thymidine (Table V) .
GPFs and Brain Development
Since GPFs might help to regulate gliogenesis, we assayed for the presence of such factors in developing neural tissues known to have ongoing glial proliferation. The specific biological activities of rat astroglia-stimulating factors were greater in embryonic cerebral cortex than those recovered from newborn animals (Fig. 9 ). There was a decline in GPF2 and GPF4 concentrations during the first postnatal week such that only very low factor levels were found in normal adult brain. In contrast, GPF~ and GPF3 were not detected in significant quantities within the cerebral cortex until the postnatal period (Fig. 9) . The peak levels of oligodendroglia- stimulating factors occurred during the first 10 d after birth declining to the low levels found in adult animals (Fig. 9) . Astroglia-stimulating GPFs appeared, therefore, during embryogenesis or at that time when astroglia first appeared in vivo; the oligodendroglia-stimulating GPFs were found in the newborn animal and were associated with a postnatal period of oligodendroglial growth and differentiation (21, 29) .
To assess age-dependent sensitivities of glia to GPFs, we assayed the action of GPG and GPF2 upon glia obtained from cerebral cortices of embryonic and newborn rats. As shown in Fig. 10 , GPF2 stimulated the appearance ofGFAI ~÷) astroglia as early as Stage 15 of the embryo. By contrast, GPFt did not promote growth of GC t÷) oligodendroglia until the time of birth. Based upon the appearance of certain GPFs in embryos (Fig. 9 ) and the response of embryonic glia to GPF2 (Fig. 10) , we concluded that the network of secretory and target cells associated with astroglia-stimulating peptides appeared earlier in development than those cells associated with oligodendroglia-stimulating peptides.
Tissue Levels of GPFs after Brain Injury
We also monitored levels of GPFs after inducing glial growth by inflicting damage to neural tissues. Stab wound injury was used to stimulate proliferation of astroglia in the adult rat brain (10) and axotomy of retinal ganglion cells to stimulate proliferation of oligodendroglia in the regenerating goldfish visual system (8, 9) . Concentrations of astroglia-stimulating factors were selectively elevated in injured rat cerebral cortex (Fig. 9) , while oligodendroglia-stimulating ones were increased in the denervated goldfish optic rectum (Fig. 11) . Since undamaged tissues in either the rat or goldfish showed far less GPF activity, we concluded that brain injury elicited production of specific GPFs that were associated with the growth of specific glial populations. Partially purified GPFt or GPF2 (each 1 t~g protein/ml culture medium) were incubated for 72 h with enriched populations of differentiated astroglia (98% GFAI ~+) cells) or oligodendroglia. The oligodendroglia populations consisted of 90% GC (+) process-bearing cells, some of which contained the A2B5 surface antigen. Data are expressed as mean number of cells per mm 2 _+ standard error observed in five cultures for each group. As shown, GPFs stimulated proliferation of specific cell populations.
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Discussion
GPFs found in the mammalian brain served as mitogens for either astroglia or oligodendroglia in culture. Based upon estimated molecular masses and specificities of action, it appeared that the GPFs isolated from the rat brain were similar to those factors recovered from fish central nervous system. This conclusion was further supported by biochemical studies described in the following report (11).
In an attempt to distinguish classes of brain-derived growth factors, we compared the glia-stimulating activities of GPFs with those of known peptide hormones. Since no identified peptide selectively stimulated proliferation of oligodendroglia, we believe that GPFt and GPF3 represent a new family of brain-derived growth factor. The identity of the astrogliastimulating GPFs is less certain, however. Although several Mixed glial cell populations obtained from newborn rat brain were incubated with 50 #1 of partially purified fish (1 gg protein/ml medium) or 50 tA of PBS in defined medium for 72 h. Oligodendroglia were identified by indirect immunofluorescence as those cells staining for GC and astroglia as those cells containing GFAP. * n, number of coverslips scored.
0.25
0.50 Figure 6 . Dose-dependent stimulation of glia by peptide factors. Glial cultures grown on poly-Llysine-coated coverslips were incubated with GPF~, GPF2, GMF, EGF, or FGF for 72 h. Mean values _+ standard error express the fold increase in cell numbers when compared with control cultures treated with matching aliquots of PBS added to 1.5 ml of defined medium. Each value is calculated from at least four cultures. Only GPF~ increased the number of oligodendroglia observed in culture. Dissociated cultures (900,000 cells/dish) obtained from newborn rat brain were incubated with partially purified GPFt (1.0 ug protein/ml medium) or GPF2 (0.7 ug protein/ml medium) in defined medium for 72 h. Specific cell populations were identified by immunofluorescence for A2B5, GC, and GFAP antigens. The data are expressed as fold increase in specific cell number when compared to control culture. Control cultures contained 21% A2B5 (÷) cells, 5% G(Y +) cells, and 37% GFAP ~+) cells.
Table IV. Effects of GPFs upon A2B5 (*) Cells
peptides (IL-1, EGF, FGF, GMF) were mitogens for astroglia, they could be distinguished from astroglia-stimulating GPFs by gel filtration chromatography. Moreover, GPF2 and GPF4 did not stimulate mouse thymocytes to incorporate thymidine as found for IL-1 and did not compete with EGF for receptor sites. Further biochemical study will, of course, be necessary to determine the structural relationships among GPFs and other classes of astroglia-stimulating peptides.
It is reasonable to suggest that GPFs regulate glial cell differentiation in developing brain. We found, for example, a correlation between the presence of GPF2 and GPF4 and the appearance of astroglia in embryos. Moreover, the levels of the oligodendroglia-promoting factors were greatest in the postnatal period, a time associated with oligodendroglial growth. Controlled release of GPFs by secretory cells might serve to regulate development of glial populations in specific regions of the central nervous system.
GPFs might also play a role in regulating glial growth after brain injury. The levels of astroglia-stimulating factors, GPF2 and GPF4, were elevated after stab wound injury to adult rat brain while, in contrast, the levels of oligodendroglia-stimulating factors, GPFI and GPF3, increased during regeneration of the goldfish visual system. Moreover, such changes in biological activities were found only in the damaged tissues. Perhaps GPFs released by injured neural tissues (6, 8, 9, 12) act to stimulate growth of glial populations near the site of injury or to provide chemotaxic signals to affect glial cell migration (8, 9) .
Our findings point to the existence of peptides within the central nervous system that regulate glial cellular responses. 100,000 isolated GO ÷) oligodendroglia grown in 15-mm plastic wells containing 500 ul of defined medium were incubated for 72 h with 5 ul (1.1 ug/ml medium) of partially purified GPF~, 5 tal (0.8 ug/ml medium) of GPF2, or 5 tal PBS. Each culture received 5 uCi of [~H] thymidine for the final 15 h of the incubation. The amount of incorporated radioactivity was determined using a glass filter assay (10) . The data are mean values of cpm -+ standard error obtained from at least four cultures and are expressed as a fold increase above the PBS control. Figure 9 . Recovery of GPFs from the cerebral cortices of embryonic (E-16), newborn, intact adult rats, and adult rats receiving stab wounds (injured). Glia-stimulating factors found in tissue sonicates were isolated by gel filtration. Specific GPFs from pooled fractions were incubated with glial cultures for 72 h. Data are expressed as fold of increase in cell number when compared with a control culture treated with aliquots of PBS. Five cultures were used for each data point. As shown, the astroglia-promoting factor, GPF2, appeared during embryogenesis, or after stab wound injury to the adult brain. The concentration of the oligodendrogiia-promoting factor, GPF~, was greatest during the early postnatal period and could not be elicited by injury. Specific activities of GPFs found in optic teetum of the regenerating visual system were compared with those of GPFs from intact optic tectum, optic tract, and cerebellum 10 d after retinal ganglion cell axotomy. Mean values + standard error express the fold of increase in cell number over control cultures. At least five cultures were used in each group. The specific activity ofGPFj, but not GPF2, increased within the optic rectum during regeneration of the visual system.
MEDIA
Although such peptides are unlikely to be the sole mediators of glial growth, shifts in GPF specific activities after brain injury and the changes observed in glial responsiveness to GPFs during development imply that these factors have important biological roles. In the following paper, we identify the probable cellular sources of GPFs in the brain ( 11 ).
